Complex Geometry in additive manufacturing design
According to REMET Inc.,” has its own process & engineering department and complex machine park which includes large-size machining equipment that allows us to produce highly processed steel structures.”
According to 3D Lab,” is a company with over 10 years of experience and an established position in the 3D printing industry. Its main focus is the delivery and maintenance of additive manufacturing devices. 3D Lab has established a leading position in the field of professional and production-oriented AM systems in the domestic market. It also provides research and development services, commercial 3D printing, and parameter optimization of metal powders melting processes. A wide scope of cooperation with leading scientific centers allows 3D Lab to offer professional, comprehensive services, including preparation of material data sheets for the produced materials.”
According to German RepRap, “create future-oriented technologies and implement them in the design and production of our 3D printers. Since 2010 we have been developing our X-Series 3D Printers based on Fused Filament Fabrication (FFF) technology. The special feature of all printers is the Open Source Platform, which makes it possible to use a variety of materials for printing. New consumables are constantly being tested and added to our product range. The Liquid Additive Manufacturing (LAM) process, liquids such as silicone rubber can also be processed.”
According to Dr. Alex Morgan, Principal at Khosla Ventures and Dr. Melanie Matheu, Prellis Biologics’ co-founder and CEO, “Regenerative medicine has made enormous leaps in recent decades. However, to create complete organs, we need to build higher-order structures like the vascular system. Prellis’ optical technology provides the scaffolding necessary to engineer these larger masses of tissues. With our investment in Prellis, we’re supporting an initiative that will ultimately produce a functioning lobe of the lung, or even a kidney, to be used in addressing an enormous unmet global need.
The human tissue engineering is the ability to build complex tissues with working vascular systems. The future of regenerative medicine revolves around harnessing the power of our own cells as therapeutics and building the tissues to keep them alive. Khosla Ventures is the perfect investor to support our merging of deep tech and cutting-edge regenerative medicine. With this technology in hand, we can begin to ask questions about real 3D cell biology that have never been asked before.”